Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
Authors:
- Im Balfour-LynnIBIm Balfour-Lynn
- A BushABA Bush
- M RosenthalMRM Rosenthal
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9338) , 978-984
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Anti‐inflammatory effects of macrolides in lung disease*Pediatric Pulmonology, 2001
- Long-term azithromycin may improve lung function in children with cystic fibrosisThe Lancet, 1998
- Interaction of macrolides with adornase during DNA hydrolysisJournal of Antimicrobial Chemotherapy, 1996
- Chlamydia pneumoniae Infection in Patients with Cystic FibrosisClinical Infectious Diseases, 1996
- In Vivo Induction of Liver P-Glycoprotein Expression by Xenobiotics in MonkeysToxicology and Applied Pharmacology, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Diffuse panbronchiolitis and cystic fibrosis: East meets West.Thorax, 1994
- Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse PanbronchiolitisRespiration, 1991
- Variability of pulmonary function tests in cystic fibrosisPediatric Pulmonology, 1990
- Statistics in Medicine: Calculating confidence intervals for some non-parametric analysesBMJ, 1988